The stock of Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) has decreased by -16.37 when compared to last closing price of 3.91. Despite this, the company has experienced a -25.68% fall in its stock price over the last five trading sessions. globenewswire.com reported 2024-07-18 that ATLANTA, July 18, 2024 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 8, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
Is It Worth Investing in Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) Right Now?
Company’s 36-month beta value is 2.08.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AVAH is 54.51M, and currently, short sellers hold a 1.74% ratio of that floaft. The average trading volume of AVAH on August 06, 2024 was 172.69K shares.
AVAH’s Market Performance
The stock of Aveanna Healthcare Holdings Inc (AVAH) has seen a -25.68% decrease in the past week, with a 29.76% rise in the past month, and a 40.34% gain in the past quarter. The volatility ratio for the week is 14.77%, and the volatility levels for the past 30 days are at 11.54% for AVAH. The simple moving average for the last 20 days is -11.43% for AVAH stock, with a simple moving average of 31.91% for the last 200 days.
Analysts’ Opinion of AVAH
UBS, on the other hand, stated in their research note that they expect to see AVAH reach a price target of $1.50. The rating they have provided for AVAH stocks is “Sell” according to the report published on November 30th, 2023.
AVAH Trading at 7.94% from the 50-Day Moving Average
After a stumble in the market that brought AVAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.43% of loss for the given period.
Volatility was left at 11.54%, however, over the last 30 days, the volatility rate increased by 14.77%, as shares surge +27.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.96% upper at present.
During the last 5 trading sessions, AVAH fell by -25.68%, which changed the moving average for the period of 200-days by +138.69% in comparison to the 20-day moving average, which settled at $3.73. In addition, Aveanna Healthcare Holdings Inc saw 22.01% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AVAH
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.31 for the gross margin
The net margin for Aveanna Healthcare Holdings Inc stands at -0.06. The total capital return value is set at 0.02. Equity return is now at value -567.05, with -6.74 for asset returns.
Based on Aveanna Healthcare Holdings Inc (AVAH), the company’s capital structure generated 1.1 points at debt to capital in total, while cash flow to debt ratio is standing at 0.0. The debt to equity ratio resting at -10.75. The interest coverage ratio of the stock is 0.13.
Currently, EBITDA for the company is 144.48 million with net debt to EBITDA at 8.23. When we switch over and look at the enterprise to sales, we see a ratio of 1.09. The receivables turnover for the company is 7.15for trailing twelve months and the total asset turnover is 1.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.88.
Conclusion
In a nutshell, Aveanna Healthcare Holdings Inc (AVAH) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
